EveryLife Issues Statement on Rare Disease Community’s Drug Pricing Considerations March 16, 2022 Share this page Senate Finance Committee Hearing, Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare Drug Pricing Related Articles FDA Rare Disease Roundtable – June 3, 2026 June 04, 2026 EveryLife Foundation Highlights Rare Disease Regulatory Recommendations and the Community’s Eagerness to Work with FDA’s New Leadership May 29, 2026 The President’s Budget Proposal: What Does It Mean for our Rare Disease Community? April 06, 2026 See All News